Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
This concise overview of the development of new therapeutics for systemic lupus erythematosus (SLE) in the past few decades considers the agents that have been tested and highlights the evolution of clinical trial design, assessment tools and outcome measures, and also provides a glimpse of several new innovations that are likely to shape drug discovery in SLE in the near future.
